161 related articles for article (PubMed ID: 32610008)
1. Identification of the Biosynthetic Gene Cluster for the anti-MRSA Lysocins through Gene Cluster Activation Using Strong Promoters of Housekeeping Genes and Production of New Analogs in
Yu L; Du F; Chen X; Zheng Y; Morton M; Liu F; Du L
ACS Synth Biol; 2020 Aug; 9(8):1989-1997. PubMed ID: 32610008
[TBL] [Abstract][Full Text] [Related]
2. In silico identification of lysocin biosynthetic gene cluster from Lysobacter sp. RH2180-5.
Panthee S; Hamamoto H; Suzuki Y; Sekimizu K
J Antibiot (Tokyo); 2017 Feb; 70(2):204-207. PubMed ID: 27553855
[No Abstract] [Full Text] [Related]
3. Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.
Zhang W; Li Y; Qian G; Wang Y; Chen H; Li YZ; Liu F; Shen Y; Du L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5581-9. PubMed ID: 21930890
[TBL] [Abstract][Full Text] [Related]
4. Yield Improvement of the Anti-MRSA Antibiotics WAP-8294A by CRISPR/dCas9 Combined with Refactoring Self-Protection Genes in Lysobacter enzymogenes OH11.
Yu L; Su W; Fey PD; Liu F; Du L
ACS Synth Biol; 2018 Jan; 7(1):258-266. PubMed ID: 29125739
[TBL] [Abstract][Full Text] [Related]
5. Facile method for site-specific gene integration in Lysobacter enzymogenes for yield improvement of the anti-MRSA antibiotics WAP-8294A and the antifungal antibiotic HSAF.
Wang Y; Qian G; Liu F; Li YZ; Shen Y; Du L
ACS Synth Biol; 2013 Nov; 2(11):670-8. PubMed ID: 23937053
[TBL] [Abstract][Full Text] [Related]
6. Identification of an Anti-MRSA Cyclic Lipodepsipeptide, WBP-29479A1, by Genome Mining of
Sang M; Wang H; Shen Y; Rodrigues de Almeida N; Conda-Sheridan M; Li S; Li Y; Du L
Org Lett; 2019 Aug; 21(16):6432-6436. PubMed ID: 31386380
[No Abstract] [Full Text] [Related]
7. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
Hamamoto H; Urai M; Ishii K; Yasukawa J; Paudel A; Murai M; Kaji T; Kuranaga T; Hamase K; Katsu T; Su J; Adachi T; Uchida R; Tomoda H; Yamada M; Souma M; Kurihara H; Inoue M; Sekimizu K
Nat Chem Biol; 2015 Feb; 11(2):127-33. PubMed ID: 25485686
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis and biological evaluation of the antibiotic lysocin E and its enantiomeric, epimeric, and N-demethylated analogues.
Murai M; Kaji T; Kuranaga T; Hamamoto H; Sekimizu K; Inoue M
Angew Chem Int Ed Engl; 2015 Jan; 54(5):1556-60. PubMed ID: 25504563
[TBL] [Abstract][Full Text] [Related]
9. Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes.
Chen X; Li S; Yu L; Miller A; Du L
Microb Biotechnol; 2019 Nov; 12(6):1430-1440. PubMed ID: 31520522
[TBL] [Abstract][Full Text] [Related]
10. Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus.
Hamamoto H; Panthee S; Paudel A; Ishii K; Yasukawa J; Su J; Miyashita A; Itoh H; Tokumoto K; Inoue M; Sekimizu K
Nat Commun; 2021 Nov; 12(1):6364. PubMed ID: 34737305
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis, regulation, and engineering of natural products from
Yue H; Miller AL; Khetrapal V; Jayaseker V; Wright S; Du L
Nat Prod Rep; 2022 Apr; 39(4):842-874. PubMed ID: 35067688
[TBL] [Abstract][Full Text] [Related]
12. Bioactive natural products from Lysobacter.
Xie Y; Wright S; Shen Y; Du L
Nat Prod Rep; 2012 Nov; 29(11):1277-87. PubMed ID: 22898908
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and Mechanism of Action of the Cell Wall Targeting Antibiotic Hypeptin.
Wirtz DA; Ludwig KC; Arts M; Marx CE; Krannich S; Barac P; Kehraus S; Josten M; Henrichfreise B; Müller A; König GM; Peoples AJ; Nitti A; Spoering AL; Ling LL; Lewis K; Crüsemann M; Schneider T
Angew Chem Int Ed Engl; 2021 Jun; 60(24):13579-13586. PubMed ID: 33768646
[TBL] [Abstract][Full Text] [Related]
14. Biosynthetic mechanism for sunscreens of the biocontrol agent Lysobacter enzymogenes.
Wang Y; Qian G; Li Y; Wang Y; Wang Y; Wright S; Li Y; Shen Y; Liu F; Du L
PLoS One; 2013; 8(6):e66633. PubMed ID: 23826105
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-throughput strategy for discovery of potent analogues of antibiotic lysocin E.
Itoh H; Tokumoto K; Kaji T; Paudel A; Panthee S; Hamamoto H; Sekimizu K; Inoue M
Nat Commun; 2019 Jul; 10(1):2992. PubMed ID: 31278250
[TBL] [Abstract][Full Text] [Related]
16. Indole-Induced Reversion of Intrinsic Multiantibiotic Resistance in Lysobacter enzymogenes.
Han Y; Wang Y; Yu Y; Chen H; Shen Y; Du L
Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28625984
[No Abstract] [Full Text] [Related]
17. Lysohexaenetides A and B, linear lipopeptides from Lysobacter sp. DSM 3655 identified by heterologous expression in Streptomyces.
Xu Q; Zou H; Pan C; Wang H; Shen Y; Li Y
Chin J Nat Med; 2023 Jun; 21(6):454-458. PubMed ID: 37407176
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structure elucidation of lipopeptide antibiotic taromycin B from the activated taromycin biosynthetic gene cluster.
Reynolds KA; Luhavaya H; Li J; Dahesh S; Nizet V; Yamanaka K; Moore BS
J Antibiot (Tokyo); 2018 Feb; 71(2):333-338. PubMed ID: 29184121
[TBL] [
